Loading data
MCHXNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 45.42 m USD | 48.12 m USD | 49.91 m USD | 52.17 m USD | 53.48 m USD |
| Cost of revenue | 16.72 m USD | 17.17 m USD | 20.58 m USD | 20.46 m USD | 21.69 m USD |
| Research and development expense | 9.75 m USD | 12.41 m USD | 15.36 m USD | 14.36 m USD | 16.11 m USD |
| Operating profit | -5.72 m USD | -4.45 m USD | -9.64 m USD | -8.15 m USD | -11.8 m USD |
| Interest expense | — | — | 282 k USD | — | 37 k USD |
| Profit before tax | -5.16 m USD | -4.57 m USD | -9.82 m USD | -8.06 m USD | -4.16 m USD |
| Income tax expense | 79 k USD | 380 k USD | 94 k USD | 184 k USD | 232 k USD |
| Net income (reported basis) | -5.24 m USD | -4.95 m USD | -9.91 m USD | -8.25 m USD | -4.39 m USD |
| Net income attributable to common shareholders | -5.24 m USD | -4.95 m USD | -9.91 m USD | -8.25 m USD | -4.39 m USD |
| Basic earnings per share | -0.12 USD/share | -0.11 USD/share | -0.23 USD/share | -0.19 USD/share | -0.1 USD/share |
| Diluted earnings per share | -0.12 USD/share | -0.11 USD/share | -0.23 USD/share | -0.19 USD/share | -0.1 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.